Current advances and challenges in the development of Acinetobacter vaccines

References

• Paterson DL, Harris PN. The New Acinetobacter Equation: Hypervirulence plus Antibiotic Resistance Equals Big Trouble. Clin Infect Dis 2015; 61:155-6; PMID:25824816
   PubMed Web of Science ®Google Scholar
• Perez F, Bonomo RA. Vaccines for Acinetobacter baumannii: thinking “out of the box”. Vaccine 2014; 32:2537-9; PMID:24662709; http://dx.doi.org/10.1016/j.vaccine.2014.03.031
   PubMed Web of Science ®Google Scholar
• Dallo SF, Weitao T. Insights into acinetobacter war-wound infections, biofilms, and control. Adv Skin Wound Care 2010; 23:169-74; PMID:20299843; http://dx.doi.org/10.1097/01.ASW.0000363527.08501.a3
   PubMed Web of Science ®Google Scholar
• Falagas ME, Karveli EA. The changing global epidemiology of Acinetobacter baumannii infections: a development with major public health implications. Clin Microbiol Infect 2007; 13:117-9; PMID:17328722; http://dx.doi.org/10.1111/j.1469-0691.2006.01596.x
   PubMed Web of Science ®Google Scholar
• Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008; 21:538-82; PMID:18625687; http://dx.doi.org/10.1128/CMR.00058-07
   PubMed Web of Science ®Google Scholar
• Towner KJ. Acinetobacter: an old friend, but a new enemy. J Hosp Infect 2009; 73:355-63; PMID:19700220; http://dx.doi.org/10.1016/j.jhin.2009.03.032
   PubMed Web of Science ®Google Scholar
• McConnell MJ, Dominguez-Herrera J, Smani Y, Lopez-Rojas R, Docobo-Perez F, Pachon J. Vaccination with outer membrane complexes elicits rapid protective immunity to multidrug-resistant Acinetobacter baumannii. Infect Immun 2011; 79:518-26; PMID:20974823; http://dx.doi.org/10.1128/IAI.00741-10
   PubMed Web of Science ®Google Scholar
• McConnell MJ, Pachon J. Active and passive immunization against Acinetobacter baumannii using an inactivated whole cell vaccine. Vaccine 2010; 29:1-5; PMID:21044668; http://dx.doi.org/10.1016/j.vaccine.2010.10.052
   PubMed Web of Science ®Google Scholar
• McConnell MJ, Rumbo C, Bou G, Pachon J. Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii. Vaccine 2011; 29:5705-10; PMID:21679737; http://dx.doi.org/10.1016/j.vaccine.2011.06.001
   PubMed Web of Science ®Google Scholar
• Gening ML, Maira-Litran T, Kropec A, Skurnik D, Grout M, Tsvetkov YE, Nifantiev NE, Pier GB. Synthetic {beta}-(1->6)-linked N-acetylated and nonacetylated oligoglucosamines used to produce conjugate vaccines for bacterial pathogens. Infect Immun 2010; 78:764-72; PMID:19948836; http://dx.doi.org/10.1128/IAI.01093-09
   PubMed Web of Science ®Google Scholar
• Bentancor LV, O'Malley JM, Bozkurt-Guzel C, Pier GB, Maira-Litran T. Poly-N-acetyl-beta-(1-6)-glucosamine is a target for protective immunity against Acinetobacter baumannii infections. Infect Immun 2012; 80:651-6; PMID:22104104; http://dx.doi.org/10.1128/IAI.05653-11
   PubMed Web of Science ®Google Scholar
• Bentancor LV, Routray A, Bozkurt-Guzel C, Camacho-Peiro A, Pier GB, Maira-Litran T. Evaluation of the trimeric autotransporter Ata as a vaccine candidate against Acinetobacter baumannii infections. Infect Immun 2012; 80:3381-8; PMID:22825448; http://dx.doi.org/10.1128/IAI.06096-11
   PubMed Web of Science ®Google Scholar
• Luo G, Lin L, Ibrahim AS, Baquir B, Pantapalangkoor P, Bonomo RA, Doi Y, Adams MD, Russo TA, Spellberg B. Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection. PloS one 2012; 7:e29446; PMID:22253723; http://dx.doi.org/10.1371/journal.pone.0029446
   PubMed Web of Science ®Google Scholar
• Lin L, Tan B, Pantapalangkoor P, Ho T, Hujer AM, Taracila MA, Bonomo RA, Spellberg B. Acinetobacter baumannii rOmpA vaccine dose alters immune polarization and immunodominant epitopes. Vaccine 2013; 31:313-8; PMID:23153442; http://dx.doi.org/10.1016/j.vaccine.2012.11.008
   PubMed Web of Science ®Google Scholar
• Russo TA, Beanan JM, Olson R, MacDonald U, Cox AD, St Michael F, Vinogradov EV, Spellberg B, Luke-Marshall NR, Campagnari AA. The K1 capsular polysaccharide from Acinetobacter baumannii is a potential therapeutic target via passive immunization. Infect Immun 2013; 81:915-22; PMID:23297385; http://dx.doi.org/10.1128/IAI.01184-12
   PubMed Web of Science ®Google Scholar
• KuoLee R, Harris G, Yan H, Xu HH, Conlan WJ, Patel GB, Chen W. Intranasal immunization protects against Acinetobacter baumannii-associated pneumonia in mice. Vaccine 2015; 33:260-7; PMID:24699469; http://dx.doi.org/10.1016/j.vaccine.2014.02.083
   PubMed Web of Science ®Google Scholar
• Fattahian Y, Rasooli I, Mousavi Gargari SL, Rahbar MR, Darvish Alipour Astaneh S, Amani J. Protection against Acinetobacter baumannii infection via its functional deprivation of biofilm associated protein (Bap). Microb Pathog 2011; 51:402-6; PMID:21946278; http://dx.doi.org/10.1016/j.micpath.2011.09.004
   PubMed Web of Science ®Google Scholar
• Chiang MH, Sung WC, Lien SP, Chen YZ, Lo AF, Huang JH, Kuo SC, Chong P. Identification of novel vaccine candidates against Acinetobacter baumanniiusing reverse vaccinology. Hum Vaccin Immunother 2015; 11(4):1065-73; PMID:25751377
   PubMed Web of Science ®Google Scholar
• Huang W, Yao Y, Long Q, Yang X, Sun W, Liu C, Jin X, Li Y, Chu X, Chen B, et al. Immunization against multidrug-resistant Acinetobacter baumannii effectively protects mice in both pneumonia and sepsis models. PloS One 2014; 9:e100727; PMID:24956279; http://dx.doi.org/10.1371/journal.pone.0100727
   PubMed Web of Science ®Google Scholar
• Cross AS, Chen WH, Levine MM. A case for immunization against nosocomial infections. J Leukocyte Biol 2008; 83:483-8; PMID:18070981; http://dx.doi.org/10.1189/jlb.0607379
   PubMed Web of Science ®Google Scholar
• Pachon J, McConnell MJ. Considerations for the development of a prophylactic vaccine for Acinetobacter baumannii. Vaccine 2014; 32:2534-6; PMID:24188749; http://dx.doi.org/10.1016/j.vaccine.2013.10.064
   PubMed Web of Science ®Google Scholar
• Garcia-Quintanilla M, Pulido MR, McConnell MJ. First steps towards a vaccine against Acinetobacter baumannii. Curr Pharm Biotechnol 2013; 14:897-902; PMID:24372252; http://dx.doi.org/10.2174/1389201014666131226123511
   PubMed Web of Science ®Google Scholar
• Fowler VG, Jr., Proctor RA. Where does a Staphylococcus aureus vaccine stand? Clin Microbiol Infect 2014; 20(Suppl 5):66-75; PMID:24476315; http://dx.doi.org/10.1111/1469-0691.12570
   PubMed Web of Science ®Google Scholar
• Leuzzi R, Adamo R, Scarselli M. Vaccines against Clostridium difficile. Hum Vaccin Immunother 2014; 10:1466-77; PMID:24637887; http://dx.doi.org/10.4161/hv.28428
   PubMed Web of Science ®Google Scholar
• Garcia-Quintanilla M, Pulido MR, Pachon J, McConnell MJ. Immunization with lipopolysaccharide-deficient whole cells provides protective immunity in an experimental mouse model of Acinetobacter baumannii infection. PloS One 2014; 9:e114410; PMID:25485716; http://dx.doi.org/10.1371/journal.pone.0114410
   PubMedGoogle Scholar
• Vella M, Pace D. Glycoconjugate vaccines: an update. Expert Opin Biol Ther 2015; 15:529-46; PMID:25496172; http://dx.doi.org/10.1517/14712598.2015.993375
   PubMed Web of Science ®Google Scholar
• Kinsella RL, Scott NE, Feldman MF. Clinical implications of glycoproteomics for Acinetobacter baumannii. Expert Rev Proteomics 2015; 12:1-3; PMID:25496064; http://dx.doi.org/10.1586/14789450.2015.987756
   PubMed Web of Science ®Google Scholar
• Hu D, Liu B, Dijkshoorn L, Wang L, Reeves PR. Diversity in the major polysaccharide antigen of Acinetobacter baumannii assessed by DNA sequencing, and development of a molecular serotyping scheme. PloS One 2013; 8:e70329; PMID:23922982; http://dx.doi.org/10.1371/journal.pone.0070329
   PubMed Web of Science ®Google Scholar
• Traub WH. Serotyping of clinical isolates of Acinetobacter baumannii and genospecies 13 capable of growth at 44°C: Detection of four new serovars. Zentralblatt für Bakteriologie 1998; 288:175-80; PMID:9809399
   PubMedGoogle Scholar
• Chopra S, Ramkissoon K, Anderson DC. A systematic quantitative proteomic examination of multidrug resistance in Acinetobacter baumannii. J Proteomics 2013; 84:17-39; PMID:23542354; http://dx.doi.org/10.1016/j.jprot.2013.03.008
   PubMed Web of Science ®Google Scholar
• Fajardo Bonin R, Chapeaurouge A, Perales J, da Silva JG, Jr., do Nascimento HJ, D'Alincourt Carvalho Assef AP, Moreno Senna JP. Identification of immunogenic proteins of the bacterium Acinetobacter baumannii using a proteomic approach. Proteomics Clin Appl 2014; 8:916-23; PMID:24899143; http://dx.doi.org/10.1002/prca.201300133
   PubMed Web of Science ®Google Scholar
• Lee JS, Kim JW, Choi CH, Lee WK, Chung HY, Lee JC. Anti-tumor activity of Acinetobacter baumannii outer membrane protein A on dendritic cell-based immunotherapy against murine melanoma. J Microbiol 2008; 46:221-7; PMID:18545973; http://dx.doi.org/10.1007/s12275-008-0052-z
   PubMed Web of Science ®Google Scholar
• Goel VK, Kapil A. Monoclonal antibodies against the iron regulated outer membrane Proteins of Acinetobacter baumannii are bactericidal. BMC Microbiol 2001; 1:16; PMID:11532195; http://dx.doi.org/10.1186/1471-2180-1-16
   PubMedGoogle Scholar
• Hosseingholi EZ, Rasooli I, Gargari SL. In silico analysis of Acinetobacter baumannii phospholipase D as a subunit vaccine candidate. Acta Biotheoretica 2014; 62:455-78; PMID:24957752; http://dx.doi.org/10.1007/s10441-014-9226-8
   PubMed Web of Science ®Google Scholar
• Moriel DG, Beatson SA, Wurpel DJ, Lipman J, Nimmo GR, Paterson DL, Schembri MA. Identification of novel vaccine candidates against multidrug-resistant Acinetobacter baumannii. PloS One 2013; 8:e77631; PMID:24116234; http://dx.doi.org/10.1371/journal.pone.0077631
   PubMed Web of Science ®Google Scholar
• Breslow JM, Meissler JJ, Jr., Hartzell RR, Spence PB, Truant A, Gaughan J, Eisenstein TK. Innate immune responses to systemic Acinetobacter baumannii infection in mice: neutrophils, but not interleukin-17, mediate host resistance. Infect Immun 2011; 79:3317-27; PMID:21576323; http://dx.doi.org/10.1128/IAI.00069-11
   PubMed Web of Science ®Google Scholar
• van Faassen H, KuoLee R, Harris G, Zhao X, Conlan JW, Chen W. Neutrophils play an important role in host resistance to respiratory infection with Acinetobacter baumannii in mice. Infect Immun 2007; 75:5597-608; PMID:17908807; http://dx.doi.org/10.1128/IAI.00762-07
   PubMed Web of Science ®Google Scholar
• Bruhn KW, Pantapalangkoor P, Nielsen T, Tan B, Junus J, Hujer KM, Wright MS, Bonomo RA, Adams MD, Chen W, et al. Host Fate is Rapidly Determined by Innate Effector-Microbial Interactions During Acinetobacter baumannii Bacteremia. J Infect Dis 2015; 211:1296-305; PMID:25378635
   PubMed Web of Science ®Google Scholar
• Qiu H, KuoLee R, Harris G, Van Rooijen N, Patel GB, Chen W. Role of macrophages in early host resistance to respiratory Acinetobacter baumannii infection. PLoS One 2012; 7:e40019; PMID:22768201; http://dx.doi.org/10.1371/journal.pone.0040019
   PubMedGoogle Scholar
• Kim SW, Choi CH, Moon DC, Jin JS, Lee JH, Shin JH, Kim JM, Lee YC, Seol SY, Cho DT, et al. Serum resistance of Acinetobacter baumannii through the binding of factor H to outer membrane proteins. FEMS Microbiol Lett 2009; 301:224-31; PMID:19878322; http://dx.doi.org/10.1111/j.1574-6968.2009.01820.x
   PubMed Web of Science ®Google Scholar
• King LB, Swiatlo E, Swiatlo A, McDaniel LS. Serum resistance and biofilm formation in clinical isolates of Acinetobacter baumannii. FEMS Immunol Med Microbiol 2009; 55:414-21; PMID:19220466; http://dx.doi.org/10.1111/j.1574-695X.2009.00538.x
   PubMed Web of Science ®Google Scholar
• Russo TA, Luke NR, Beanan JM, Olson R, Sauberan SL, MacDonald U, Schultz LW, Umland TC, Campagnari AA. The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor. Infect Immun 2010; 78:3993-4000; PMID:20643860; http://dx.doi.org/10.1128/IAI.00366-10
   PubMed Web of Science ®Google Scholar
• Qiu H, KuoLee R, Harris G, Chen W. High susceptibility to respiratory Acinetobacter baumannii infection in A/J mice is associated with a delay in early pulmonary recruitment of neutrophils. Microbes Infect 2009; 11:946-55; PMID:19573619; http://dx.doi.org/10.1016/j.micinf.2009.06.003
   PubMed Web of Science ®Google Scholar
• Trzcinski K, Thompson CM, Srivastava A, Basset A, Malley R, Lipsitch M. Protection against nasopharyngeal colonization by Streptococcus pneumoniae is mediated by antigen-specific CD4+ T cells. Infect Immun 2008; 76:2678-84; PMID:18391006; http://dx.doi.org/10.1128/IAI.00141-08
   PubMed Web of Science ®Google Scholar
• Leef M, Elkins KL, Barbic J, Shahin RD. Protective immunity to Bordetella pertussis requires both B cells and CD4(+) T cells for key functions other than specific antibody production. J Exp Med 2000; 191:1841-52; PMID:10839801; http://dx.doi.org/10.1084/jem.191.11.1841
   PubMed Web of Science ®Google Scholar
• Bist P, Dikshit N, Koh TH, Mortellaro A, Tan TT, Sukumaran B. The Nod1, Nod2, and Rip2 axis contributes to host immune defense against intracellular Acinetobacter baumannii infection. Infect Immun 2014; 82:1112-22; PMID:24366254; http://dx.doi.org/10.1128/IAI.01459-13
   PubMed Web of Science ®Google Scholar
• Hartzell JD, Kim AS, Kortepeter MG, Moran KA. Acinetobacter pneumonia: a review. MedGenMed 2007; 9:4; PMID:18092011
   PubMedGoogle Scholar
• Joly-Guillou ML, Wolff M, Pocidalo JJ, Walker F, Carbon C. Use of a new mouse model of Acinetobacter baumannii pneumonia to evaluate the postantibiotic effect of imipenem. Antimicrob Agents Chemother 1997; 41:345-51; PMID:9021190
   PubMed Web of Science ®Google Scholar
• Harris G, Kuo Lee R, Lam CK, Kanzaki G, Patel GB, Xu HH, Chen W. A mouse model of Acinetobacter baumannii-associated pneumonia using a clinically isolated hypervirulent strain. Antimicrob Agents Chemother 2013; 57:3601-13; PMID:23689726; http://dx.doi.org/10.1128/AAC.00944-13
   PubMed Web of Science ®Google Scholar
• Jacobs AC, Thompson MG, Black CC, Kessler JL, Clark LP, McQueary CN, Gancz HY, Corey BW, Moon JK, Si Y, et al. AB5075, a highly virulent isolate of Acinetobacter baumannii, as a model strain for the evaluation of pathogenesis and antimicrobial treatments. mBio 2014; 5:e01076-14; PMID:24865555; http://dx.doi.org/10.1128/mBio.01076-14
   PubMed Web of Science ®Google Scholar
• Russo TA, Beanan JM, Olson R, MacDonald U, Luke NR, Gill SR, Campagnari AA. Rat pneumonia and soft-tissue infection models for the study of Acinetobacter baumannii biology. Infect Immun 2008; 76:3577-86; PMID:18541654; http://dx.doi.org/10.1128/IAI.00269-08
   PubMed Web of Science ®Google Scholar
• Li ZT, Zhang RL, Bi XG, Xu L, Fan M, Xie D, Xian Y, Wang Y, Li XJ, Wu ZD, et al. Outer membrane vesicles isolated from two clinical Acinetobacter baumannii strains exhibit different toxicity and proteome characteristics. Microb Pathog 2015; 81:46-52; PMID:25773772; http://dx.doi.org/10.1016/j.micpath.2015.03.009
   PubMed Web of Science ®Google Scholar